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Abstract
Background: Few studies have examined associations between access to health care and childhood vaccine
coverage in remote communities that lack motorised transport. This study assessed whether travel time to health
facilities was associated with childhood vaccine coverage in a remote area of Ethiopia.
Methods: This was a cross-sectional study using data from 775 children aged 12–59 months who participated in a
household survey between January –July 2010 in Dabat district, north-western Ethiopia. 208 households were
randomly selected from each kebele. All children in a household were eligible for inclusion if they were aged
between 12–59 months at the time of data collection. Travel time to vaccine providers was collected using a
geographical information system (GIS). The primary outcome was the percentage of children in the study
population who were vaccinated with the third infant Pentavalent vaccine ([Diphtheria, Tetanus,-Pertussis Hepatitis
B, Haemophilus influenza type b] Penta3) in the five years before the survey. We also assessed effects on BCG,
Penta1, Penta2 and Measles vaccines. Analysis was conducted using Poisson regression models with robust
standard error estimation and the Wald test.
Results: Missing vaccination data ranged from 4.6% (36/775) for BCG to 16.4% (127/775) for Penta3 vaccine. In
children with complete vaccination records, BCG vaccine had the highest coverage (97.3% [719/739]), Penta3
coverage was (92.9% [602/648]) and Measles vaccine had the lowest coverage (81.7% [564/690]). Children living
≥60mins from a health post were significantly less likely (adjRR = 0.85 [0.79-0.92] p value<=0.001) to receive Penta3
vaccine compared to children living <30mins from a health post. This effect was not modified by household
wealth (p value = 0.240). Travel time also had a highly significant association with BCG (adjRR = 0.95 [0.93-0.98]
p value =0.002) and Measles (adjRR = 0.88 [0.79-0.97] p value =0.027) vaccine coverage.
Conclusions: Travel time to vaccine providers in health posts appeared to be a barrier to the delivery of infant
vaccines in this remote Ethiopian community. New vaccine delivery strategies are needed for the hardest to reach
children in the African region.
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Background
Vaccines are one of the most effective interventions that
can be used to prevent mortality in children under five
years [1]. Improving access to childhood vaccines in low-
income countries has been a major goal of public health
services both at international and national levels [1].
However, achieving high and equitable coverage remains
a challenge in low income countries like Ethiopia [2].
Ethiopia has implemented the World Health
Organization (WHO) Expanded Programme on Immun-
isation (EPI) schedule since 1980 [2]. The EPI now tar-
gets eight diseases: Tuberculosis, Poliomyelitis,
Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus
influenzae type b and Measles and prescribes eight vac-
cines to be administered to children in their first year of
life [3]. UNICEF and WHO have prioritised vaccination
of children from the “hardest to reach” populations in-
cluding those with limited geographical access to health
facilities [4] and programs such as ‘Reaching Every Dis-
trict’ (RED) and ‘National Immunisation Days (NIDs)’
have been introduced in many countries including Ethi-
opia [5]. These programs appear to have improved ac-
cess to vaccines across Ethiopia. However, over one third
of families in rural Ethiopia still have to walk more than
60 minutes to reach health posts for vaccines [6].
In response to these concerns Ethiopia’s health sector
reform plan has included a Health Extension Program to
improve access and equity to health interventions includ-
ing immunisation services for the rural poor [7]. This has
included the staffing of health posts in remote areas to
provide basic services such as health education and
childhood immunisation. The Health Extension Program
has improved quality and reduced travel time to vaccin-
ation services and may have reduced many barriers to
the implementation of vaccine programs in remote areas.
However, the impact of these programs in the poorest
and most remote regions is unknown. The primary ob-
jective of this study was to assess whether travel time to
health posts was associated with childhood vaccine
coverage in a remote area of rural Ethiopia. Secondary
objectives were to assess if vaccination coverage varied
by household wealth status and if the effect of travel time
on vaccine coverage was modified by household wealth.
Methods
Study area
The study was implemented in the Dabat Health and
Demographic Surveillance Site (HDSS) in Dabat district,
north-western Ethiopia. The HDSS consists of three
urban and seven rural kebeles - the smallest administra-
tive unit in Ethiopia. The population in the HDSS is cur-
rently 46,165 and is dominated by the Amhara ethnic
group [8]. A typical house has walls constructed from
mud and wood. Livestock are commonly kept in the
house and the economy is mainly based on subsistence
farming and trading. There are few roads in this part of
Ethiopia. Off-road motorised transport is not viable in
most areas because of the difficult terrain. The main
form of travel is walking and the mountainous region
and poor road network means that families spend many
hours walking to farms, health facilities and administra-
tive centres. The under five mortality rate in Dabat dis-
trict has recently been reported as 130 per 1,000 live
births [9].
The vaccine schedule in Dabat district comprises:
Bacille Calmette Guérin (BCG); Pentavalent vaccine
(Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemo-
philus influenzae type b vaccines combined in one syr-
inge) at 6 weeks (Penta 1), 10 weeks (Penta2) and
14 weeks (Penta3); oral polio vaccine (OPV) at 6 weeks
(Polio1), 10 weeks (Polio2) and 14 weeks (Polio3) and
measles vaccine at 9 months.
There are a total of 8 rural health posts in Dabat dis-
trict (one kebele has two health posts and all other rural
kebeles have one health post). In Dabat district, vaccines
are mostly administered in the health posts. Health posts
are the lowest level of health care and staffed by two fe-
male health extension workers recruited from the com-
munity and trained for one year to provide a range of
essential health interventions including childhood im-
munisation for the rural population [10]. Vaccines are
provided approximately once a month to all children
attending the health post [3]. Due to limited time and
staffing the health extension workers do not perform
home visits to provide vaccines. There are no refrigera-
tors to keep the vaccines in the health posts and they
are brought in a vaccine carrier from Dabat health
centre on the scheduled date for immunisation and left
over vaccines are taken back to the health centre the
same day. The other source of vaccine delivery in the
study area is the national immunisation days. These are
currently used for Polio and Measles vaccines and are
implemented by national immunisation staff in commu-
nity locations (e.g. village market places, schools,
churches or mosques) as well as the health posts.
Study design
This was a cross-sectional study conducted in the seven
rural kebeles of the HDSS between January and July
2010. 208 households were randomly selected from a list
of the rural kebele households supplied by the HDSS
using a computer generated sequence. Children were eli-
gible for inclusion if they were aged between 12–
59 months at the time of data collection.
Data collection
Trained data collectors visited households and identified
eligible children who were present at the time of the
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survey. Information recorded during the interview
included: demographic characteristics of mothers,
household asset information needed for the construction
of wealth terciles, the place of the child’s birth and
whether delivery was assisted by skilled birth attendants.
After obtaining informed written consent from the
child’s mother, the data collectors asked the mothers
questions and entered the responses directly into the
hand-held computers (PDAs). Vaccination data for five
vaccines (BCG, Penta1, Penta2, Penta3 and Measles)
were recorded from the vaccine card obtained from the
mother at the beginning of the interview. If there was no
card, data were obtained from the mother, based on her
memory about the vaccination. Immunisation data were
double checked from the health post vaccination register
book and information was added or corrected where
needed. Polio vaccination data were not recorded as
both maternal recall and health post registration for
these vaccines was very poor.
Geographical access data
Methods for calculation of the measures of geographical
access are detailed elsewhere [9]. In brief, travel time
was calculated using the “Cost analysis” module in the
IDRISI Taiga Geographic Information System (GIS) soft-
ware package. The module requires two input layers of
data. The first layer contains the target location (the
health posts), and the second layer contains the costs (in
terms of the time spent walking) associated with moving
through different geographical features in the study area
to reach the target feature. Different features (e.g. walk-
ing up hills and mountains and traversing through
water) are assigned different speeds. The output from
the module is an image where each cell (pixel) in the
image contains values of travel time required to traverse
from that cell to the health post. In this study, a speed
of 5 km/hr was assigned for all walking routes, slopes
greater than 30 degrees were assigned a speed of
0.1 km/hr and traversing through water bodies was also
assigned a speed of 0.1 km/hr. Travel time for each
household was extracted and exported into Stata to
merge with the main dataset. Validation of the model
was described in detail in our previous paper [9]. In
brief, reported travel time from 40 village centre were
obtained and compared with estimated travel time.
Mean reported and estimated travel times were very
close (mean, 73 vs. 67 minutes; standard deviation, 46
vs. 40 minutes, respectively).
Statistical methods
All analyses were performed in Stata SE 12.0 (StataCorp
LP, College Station, TX 77845, USA). Travel time was
examined as a categorical variable divided into terciles
(<30mins, 30-< 60mins and ≥60 mins) and as a
continuous variable (based on the number of minutes of
travel time from the household to the health post).
The primary outcome variable was the percentage
of children aged 12–59 months who received Penta3
vaccine at any time before the survey was conducted.
This vaccine was chosen as it is most commonly
used by international groups such as WHO and
UNICEF [11].
To estimate the wealth status of each household, we
constructed a relative asset index based on data col-
lected on housing material and household assets. The
index was constructed using principal component ana-
lysis (PCA). Children in the sample were ranked in order
of the asset index values for their households, and then
they were divided into one of three equal sized terciles,
ranking from the least poor to the poorest.
In the univariable analyses, we first assessed associa-
tions between Penta3 coverage, travel time, household
wealth and potential confounding variables such as:
demographic characteristics of mothers (age group, edu-
cation level, and parity). In the multivariable analysis we
investigated the relationship between the probability of
receiving Penta3 vaccine and travel time to health posts
using Poisson regression models with robust standard
error estimation. We first accounted for the intra cluster
correlation of many children from the same mother,
many mothers from the same village and many villages
from the same kebele. However, there was only evidence
of within kebele clustering of vaccination coverage and
no evidence of clustering at the village or mother level.
Thus, the final model only adjusted for clustering at the
kebele level. The model also included confounding vari-
ables which had p value of <0.1 for their association
with travel time to health posts and vaccine coverage.
We also examined statistical interactions between travel
time and household wealth status and hypothesised a
priori that the effect of travel time on vaccine coverage
might be different in rich and poor women. The Wald
test was used to compare the fit of models containing
different variables, to test for trend in ordered categor-
ical variables and to test for a statistical interaction be-
tween travel time and household wealth. These analyses
were repeated for the four other vaccines (BCG, Penta1,
Penta2 and Measles).
Sample size
The most recent Ethiopian Demographic and Health
Survey (DHS) reported 32% of children aged 12–59
months are immunised with Penta3 vaccine by age 12
months [12]. The Dabat HDSS reported that there were
approximately 600 children aged 12–59 months in the
study area. We calculated that these children would pro-
vide 80% power at a 5% significance level to detect at
least a 10% difference in Penta3 vaccination coverage
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Figure 2 Vaccine coverage in children aged 12–59 months in Dabat, rural Ethiopia. *Number of children who received vaccine / number
of children with vaccination data (excluding those with missing vaccination data). **Vaccine coverage (%).
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between children who lived< 60 minutes from a health
post compared to those who lived ≥ 60 minutes.
Ethical considerations
This study was approved by the ethical review commit-
tees of the University of Gondar and the London
School of Hygiene and Tropical Medicine. Verbal
informed consent to conduct interviews was received
from all heads of participating households. Written
informed consent to participate in the study was
obtained from mothers of all children who were
included in the study.
Results
Study population
We visited 1,453 households in 7 rural kebeles. All
households were visited and all women in these house-
holds were able to be interviewed. 775 children were
aged between 12–59 months. Of these, 380 (49%) were
female; 494 (65%) lived <60 mins walking travel time
from the health post; the overall mean travel time was
55 mins (standard deviation [sd] 33 mins) and the me-
dian was 51 mins (interquartile range [IQR] 0-168mins).
The mean travel time by location of kebele ranged from
37–81 mins (Figure 1). 355 (53%) of the mothers were
aged over 30 years. The mean number of children per
Table 1 Vaccine coverage in children with complete vaccination records aged 12–59 months, by sociodemographic











Sex Boys 342(96%)** 337(96%) 316(95%) 299(94%) 272(81%)
Girls 354(98%) 335(95%) 302(92%) 285(92%) 277(83%)
Missing data 23 23 19 18 15
p-value 0.162 0.277 0.095 0.237 0.449
Location Kebele1 93(97%) 52(68%) 40(62%) 31(86%) 68(82%)
Kebele2 123(99%) 123(99%) 117(99%) 114(99%) 96(85%)
Kebele3 121(100%) 121(100%) 120(99%) 120(99%) 94(81%)
Kebele4 87(99%) 89(95%) 69(97%) 67(93%) 76(83%)
Kebele5 98(94%) 104(100%) 100(97%) 89(86%) 75(80%)
Kebele6 112(92%) 121(00%) 107(91%) 97(84%) 84(71%)
Kebele7 85(100%) 85(100%) 84(99%) 84(98%) 71(96%)
Missing data - - - - -
p-value 0.001 <=0.0001 <=0.0001 <=0.0001 0.003
Mother’s education Education 110(100%) 100(95%) 94(94%) 92(95%) 91(85%)
No education 587(97%) 573(96%) 525(94%) 493(93%) 459(82%)
Missing data 22 20 18 17 14
p-value 0.053 0.786 0.975 0.259 0.422
Mother’s age 16-< 25y 147(98%) 138(95%) 127(91%) 117(87%) 109(79%)
25-< 30y 184(96%) 182(94%) 168(93%) 158(95%) 149(83%)
30-< 35y 163(99%) 156(96%) 142(96%) 139(96%) 130(85%)
35-< 50y 203(96%) 197(97%) 182(96%) 171(93%) 162(81%)
Missing data 22 22 18 17 14
p-value 0.188 0.446 0.162 0.019 0.503
Parity 1 56(98%) 52(93%) 51(93%) 47(90%) 42(82%)
2-3 216(99%) 204(95%) 187(92%) 177(93%) 166(82%)
4-5 215(96%) 207(94%) 189(93%) 177(92%) 167(83%)
6-12 210(96%) 210(98%) 192(96%) 184(94%) 175(82%)
Missing data 22 22 18 17 14
p-value 0.392 0.074 0.347 0.768 0.989
* Total number of children who were vaccinated.
** Number of children vaccinated (number of children vaccinated / number of children with vaccination data).
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woman was 4.0 (sd 2.1) and the mean age of the
mothers interviewed was 29 years (sd 7.1). 280 (37%)
children lived in the poorest and 203 (27%) in the least
poor households. Only 17 (2.1%) were born at a health
facility and 16 (2.0%) of births were attended by a skilled
birth attendant.
Figure 2 summarises vaccination coverage for the five
vaccines in children aged 12–59 months. Missing vac-
cination data ranged from 4.6% (36/775) for BCG to
16.4% (127/775) for Penta3 vaccine. In children with
complete vaccination records, BCG vaccine had the
highest coverage (97.3% [719/739]), Penta3 coverage was
(92.9% [602/648]) and Measles vaccine had the lowest
coverage (81.7% [564/690]).
Socio demographic characteristics
Table 1 shows the univariable analysis of association, in
children with complete vaccination records, between
vaccination coverage and child’s sex, location, mother’s
education, mother’s age and parity for each of the vac-
cines. There was little variation in vaccination coverage
by child’s sex, mother’s age or education level. However,
there was marked variation by kebele.
Travel time
Table 2 displays the Poisson regression analysis for both
the crude and adjusted assessment of the effect of travel
time to health posts on the risk of being vaccinated
against BCG, Penta1, Penta2, Penta3 and Measles. Travel
time appeared to have a highly significant association
with Penta3 vaccine coverage. Children living ≥60mins
from a health post were significantly less likely (adjRR
0.85 [0.79-0.92] p-value<=0.0001) to receive Penta3
vaccine compared to children living <30mins from a
health post (Table 2 and Figure 3). Travel time also had
a highly significant association with BCG (adjRR = 0.95
[0.93-0.98] p value =0.002) and Measles, (adjRR = 0.88
[0.79-0.97] p value =0.027) vaccine coverage.
Adjusting for household wealth, mother’s age, educa-
tion, and parity had little effect on all effect measures in
the multivariable analyses.
Household wealth
Table 2 displays the Poisson regression analysis for both
the crude and adjusted analysis of the effect of house-
hold wealth on the risk of being vaccinated against BCG,
Penta1, Penta2, Penta3 and Measles. There appeared to
be no association between household wealth and cover-
age of any vaccine. There was also no statistical evidence
of modification of the effect of travel time on Penta3
vaccine coverage by household wealth (p value = 0.240)
or on any other vaccine (Table 3).
Discussion and Conclusions
Travel time to vaccine providers in health posts
appeared to be a barrier to the delivery of infant vaccines
in this remote community. However, there appeared to
be no differential or modification of this effect by house-
hold wealth. We recently reported that geographic ac-
cess to the major health centre in the study area was an
Table 2 Poisson regression analysis of the association between travel time to health posts and vaccine coverage in
children with complete vaccination records aged 12–59 months in Dabat, rural Ethiopia
Variables Travel time Vaccinated (%) Crude RR (95%CI) Adjusted RR (95%CI)** P-value***
BCG(n=739)* 0-< 30 min 241(97%) 1 1 -
30-< 60mins 240(94%) 0.98(0.97-1.00) 0.98(0.97-1.00) 0.071
>= 60mins 238(86%) 0.95(0.93-0.98) 0.95(0.93-0.98) 0.002
Penta 1(n= 725) 0-< 30 min 238(96%) 1 1 -
30-< 60mins 217(85%) 0.93 (0.84-1.04) 0.93 (0.84-1.04) 0.234
>= 60mins 240(88%) 0.95(0.86-1.04) 0.95(0.86-1.04) 0.275
Penta 2(n= 679) 0-< 30 min 223(90%) 1 1 -
30-< 60mins 199(78%) 0.92(0.82-1.04) 0.92(0.82-1.04) 0.197
>= 60mins 215(78%) 0.94(0.89-0.99) 0.94(0.89-0.99) 0.030
Penta 3(n= 648) 0-< 30 min 220(89%) 1 1 -
30-< 60mins 191(75%) 0.96(0.94-1.00) 0.92(0.89-0.96) 0.034
>= 60mins 191(70%) 0.85(0.79-0.92) 0.85(0.79-0.92) <0.0001
Measles(n= 690) 0-< 30 min 198(80%) 1 1 -
30-< 60mins 188(74%) 0.95(0.89-1.02) 0.95(0.89-1.02) 0.214
>= 60mins 178(65%) 0.88(0.79-0.97) 0.88(0.79-0.97) 0.027
*Total number of children with complete vaccination records.
**Adjusted for household wealth, mother’s education, parity and mother’s age.
***P values from Wald test.
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important determinant of both early and late child mor-
tality [9,13-15]. Our analyses now indicate that travel
time also effects the implementation of preventative
interventions such as infant vaccination.
Our findings were clearly defined for all vaccines,
though the effect was strongest for pentavalent
vaccine. This may be due to the fact that pentava-
lent vaccines are only delivered at the static health
posts while Measles vaccines are given through sup-
plemental immunisation activities [16-18] within the
villages and BCG vaccines are given at the time of
delivery.
>=60min(70%)





Figure 3 Proportion of children aged 12–59 months who received Penta3 vaccination by travel time to health posts in Dabat, rural
Ethiopia. * Mean travel time (vaccine coverage, %).
Table 3 Poisson regression analysis of the association between household wealth and vaccine coverage in children
with complete vaccination records aged 12–59 months, in Dabat, rural Ethiopia
Variables Household wealth Immunised (%) Crude RR (95%CI) Adjusted RR (95%CI)** P-value***
BCG(n=739)* Least poor 182(90%) 1 1 -
Middle 249(92%) 1.01(0.96, 1.07) 1.02(0.95,1.07) 0.643
Poorest 266(95%) 1.03(0.98,1.08) 1.03(0.98,1.08) 0.152
Penta 1(n= 725) Least poor 172(85%) 1 1 -
Middle 245(91%) 1.00(0.98,1.03) 1.01(0.98,1.04) 0.463
Poorest 256(91%) 0.99(0.94,1.05) 1.00(0.94,1.07) 0.756
Penta 2 (n= 679) Least poor 162(80%) 1 1 -
Middle 224(83%) 0.96(0.91,1.03) 0.96(.091,1.03) 0.409
Poorest 233(83%) 0.97(0.93,1.02) 0.97(0.93,1.02) 0.728
Penta 3 (n= 648) Least poor 151(74%) 1 1 -
Middle 212(78%) 1.03(0.97,1.10 1.04(0.98,1.10) 0.221
Poorest 222(79%) 1.01(0.96,1.06) 1.02(0.97,1.08) 0.414
Measles (n =690) Least poor 146(72%) 1 1 -
Middle 202(75%) 0.98(0.89,1.08) 0.98(0.89,1.08) 0.720
Poorest 202(72%) 0.96(0.89,1.08) 0.96(0.89,1.04) 0.402
*Total number of children with complete vaccination records.
**Adjusted for travel time to health posts, mother’s education, parity and mother’s age.
***P values from Wald test.
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This appears to be the first study that has examined
associations between geographical access to health facil-
ities and childhood vaccination coverage throughout in-
fancy in such a remote area of Africa. This also appears
to be the first study that reports that Measles vaccin-
ation may be less effected by geographic disparities than
other vaccines. Studies from Tanzania [19], Malawi [20],
Nigeria [21], Kenya [22] and Papua New Guinea [23], all
indicated that travel time to health facilities was a barrier
to receipt of all infant vaccines including Measles [23].
Studies from more densely populated areas such as
Kenya found no association between the coverage of any
infant vaccines and travel time to health facilities [24-
26]. This was thought to be due to the high density of
health centres and health posts rather than the effect of
supplementary immunisation activities or other Ministry
of Health strategies.
Interestingly there was a marked association between
vaccination coverage and kebele. This may be due to dif-
ferences in quality of services or other barriers such as
social constraints or staffing levels in the different
kebeles. However, we did not adjust the results for travel
time or other potential confounding factors and further
analyses are needed to explore this issue. There was also
little variation in vaccination coverage by household
wealth, maternal age or education. This is likely to be
due to the marked homogeneity in our study population
and we reported similar effects in our earlier mortality
study [9].
There were several limitations to our study. Firstly, we
were not able to assess coverage of important vaccines
such as Polio due to problems with reporting. Secondly,
we were only able to assess effects on vaccination cover-
age and could not examine effects on health outcomes
such as vaccine preventable diseases or hospitalisations
due to limited resources. Thirdly, as this was a cross sec-
tional study, travel time was assigned at the point at
which the mothers were interviewed and there was no
ongoing tracking of migration. Thus there may have
been some misclassification of travel time status.
Fourthly, the timeliness of the vaccination was not eval-
uated in this study as mothers recall was considered to
be too poor. Finally, we may have overestimated the per-
centage of vaccinated children as we only included sur-
viving children in our study and we might have missed
unvaccinated children who had died [27,28]. In addition,
our coverage data were calculated using children aged
12–59 months and are likely to be higher than other
studies and the DHS which use younger children aged
12–23 months [29]. Five to seventeen percents of vac-
cine data was also unknown or missing in our study,
however, any differential misclassification of vaccination
status would have tended to underestimate rather than
overestimate effect sizes. Also, important strengths of
our study were our careful collection of health facility
data on vaccination and our reporting of potential con-
founders such as maternal education and household
wealth. We also used a three-level-level random effects
model to account adequately for clustering by mother,
village and kebele. We also used a validated access meas-
ure [30] (travel time) from each household to the health
posts which accounted for the influence of topography
and other natural barriers.
Our study has important implications for policy and
program development. Vaccination coverage can be
improved in remote areas by improving access and redu-
cing travel time to health facilities. Supplementary im-
munisation activities may also be contributing to
improvements in measles immunisation coverage in later
infancy and reduction in inequalities. Where appropri-
ate, outreach programs and supplemental immunisation
activities should be considered for raising coverage in re-
mote areas. In addition, new vaccine delivery strategies
are needed for the hardest to reach children in Ethiopia
and other parts of sub-Saharan Africa.
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